Clinical practice of health professionals working in early detection for infants with or at risk of cerebral palsy across New Zealand. (20th November 2020)

• Record Type: Journal Article
• Authors: Williams, Sîan A; Mackey, Anna; Sorhage, Alexandra; Battin, Malcolm; Wilson, Nichola; Spittle, Alicia; Stott, N Susan
• Is Part Of: Journal of paediatrics and child health. Volume 57:Number 4(2021)
• Page Start: 541
• Page End: 547
• Publication Date: 2020-11-20
• Subjects: diagnostic tool -- early diagnosis -- general movements assessment -- Hammersmith Infant Neurological Examination; Children -- Health and hygiene -- Periodicals; Pediatrics -- Periodicals; 618.92
• DOI: 10.1111/jpc.15263
• Languages: English
• ISSNs: 1034-4810

Abstract

Abstract : Aim: A diagnosis of cerebral palsy (CP) can, and should, be made as early as possible. This work describes current clinical practice around the awareness and use of diagnostic tools for the detection of CP in New Zealand (NZ). Methods: A purpose‐developed survey distributed electronically to NZ clinicians working with young children with or at risk of CP. Results: A total of 159 clinicians (including paediatricians, physiotherapists and occupational therapists) participated in this cross‐sectional study. Ninety‐six percent were aware that a diagnosis of CP can be made by 12 months of age, with high levels of awareness of the use of magnetic resonance imaging (94%), Prechtl's qualitative assessment of general movements (GMs) (70%) and Hammersmith Infant Neurological Examination (HINE) (77%). Only 40% were aware of the HINE optimality scoring. Fifty‐four clinicians provided a diagnosis of CP as part of their role: 48% never used the GMs or HINE to assess children <1 year, and 57% never used the HINE for children between 1 and 2 years. Clinicians not providing a diagnosis within their professional role ( n = 104) also indicated infrequent use of assessment tools with 74% and 54% never using the GM's or HINE (respectively) in their assessment of children at risk of CP. Barriers to use included lack of time and funding, lack of clear pathways and management support. Conclusion: Despite high awareness, current use of international best practice tools in NZ clinical practice appears low. Multiple barriers are reported to the use of these tools, which need to be addressed to improve the timeliness of diagnosis.